Molecular machine and preparation method of Dendrobium officinale polysaccharide extract and its anti-oxidation and anti-aging application
Through hydrogen bond recognition and ultrasonic strengthening of the lactate-based molecular machine and Dendrobium officinale polysaccharide, the problems of low efficiency and high cost of Dendrobium officinale polysaccharide extraction are solved, and efficient and stable polysaccharide extraction and antioxidant and anti-aging effects are achieved.
Patent Information
- Application Number
- CN202410881587.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-03
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2044-07-03
AI Technical Summary
In the prior art, the extraction efficiency of Dendrobium officinale polysaccharide is low and costly, the water extraction efficiency is low and there are many impurities, and the organic solvents have safety and environmental problems. Traditional alcohol solvents have low solubility to polysaccharide compounds, resulting in low extraction efficiency.
The lactate-based molecular machine is used to identify and connect with Dendrobium officinale polysaccharide through hydrogen bond drive, combined with ultrasonic strengthening treatment and centrifugal filtration to prepare a method to efficiently extract Dendrobium officinale polysaccharide, avoiding enzyme catalysis and the use of organic solvents, improving extraction efficiency and stability sex.
Improve the extraction efficiency of Dendrobium officinale polysaccharide, reduce costs, and achieve high-quality and stable production. Polysaccharide compounds have good stability in the lactic acid-based molecular machine system, avoiding the growth of microbial organisms and the presence of impurities. The extract can be used for antioxidant and Anti-aging skin care products.
Smart Images

Figure CN118416531B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of extracting polysaccharides from Dendrobium officinale, and in particular to a molecular machine and a preparation method of a polysaccharide extract from Dendrobium officinale and its anti-oxidation and anti-aging applications. Background Art
[0002] Dendrobium candidum is a herbal medicinal plant of the genus Dendrobium in the orchid family. It is mainly distributed in Anhui, Sichuan, Zhejiang, Yunnan, Jiangxi and other places in my country. Modern research has found that Dendrobium candidum is rich in polysaccharides, flavonoids, and polyphenol compounds, and has excellent antioxidant, anti-inflammatory, anti-aging, and antiviral effects. Therefore, it is of great significance to carry out research on the extraction solvent and process of its main active substance polysaccharide.
[0003] At present, the main extraction solvents for polysaccharides from Dendrobium officinale are water and organic solvents. The water extraction method has problems such as low extraction efficiency and many impurities. The organic solvents involved in the organic solvent extraction method are toxic and polluting, flammable and explosive, difficult to separate or separate in the future, and the detection cost is too high. In addition, the solubility of traditional alcohol solvents for polysaccharides is low, and the extraction efficiency of polysaccharides is low.
[0004] The existing technology for extracting polysaccharides from Dendrobium officinale has the problem of high efficiency and low cost. Summary of the invention
[0005] The present application provides a molecular machine and a method for preparing a polysaccharide extract of Dendrobium officinale and its antioxidant and anti-aging applications, so as to solve the problem of high efficiency and low cost in extracting polysaccharides of Dendrobium officinale.
[0006] In a first aspect, an embodiment of the present application provides a lactic acid-based molecular machine, comprising a first functional motif and a second functional motif;
[0007] The first functional motif is bonded to the second functional motif via a hydrogen bond;
[0008] The first functional motif is a lactic acid molecule, and the second functional motif is at least one of a betaine molecule, a matrine molecule or a L-carnitine molecule;
[0009] Among them, the polysaccharide of Dendrobium officinale includes O-acetyl β-D-glucomannan, the main chain of which is composed of D-mannose and D-glucose linked by β-1,4 glycosidic bonds;
[0010] The lactic acid-based molecular machine is used to drive the lactic acid-based molecular machine to recognize and connect with the Dendrobium officinale polysaccharide through the affinity of the hydrogen bond, including driving the lactic acid-based molecular machine to recognize and connect with the β-1,4 glycosidic bond of the Dendrobium officinale polysaccharide through the affinity of the hydrogen bond;
[0011] Wherein, when the second functional unit is the betaine molecule, the molecular structural formula of the molecular machine is CH3CH(OH)COO-H-OOCCH2N(CH3)3.
[0012] In a second aspect, an embodiment of the present application provides a method for preparing a lactic acid-based molecular machine as described in the first aspect, comprising the following steps: mixing at least one of the betaine, matrine or L-carnitine with the lactic acid to obtain a mixed solution, and heating the mixed solution until the viscosity of the mixed solution is 200 mPa•s~500 mPa•s to obtain a lactic acid-based molecular machine;
[0013] Wherein, the temperature of the heating treatment is 30 ℃~60 ℃.
[0014] In a third aspect, the present application provides a method for preparing a polysaccharide extract of Dendrobium officinale, comprising the following steps:
[0015] Step S100, mixing the Dendrobium officinale powder and the lactic acid-based molecular machine solution and then performing ultrasonic strengthening treatment to obtain a Dendrobium officinale extract;
[0016] Step S200, centrifuging the Dendrobium officinale extract, filtering the supernatant after the centrifugation to obtain a Dendrobium officinale polysaccharide extract;
[0017] Wherein, the solute in the lactic acid-based molecular machine solution is the lactic acid-based molecular machine described in the first aspect, and / or, is the lactic acid-based molecular machine prepared by the preparation method described in the second aspect.
[0018] In the fourth aspect, the embodiments of the present application provide an antioxidant and anti-aging application of a Dendrobium officinale polysaccharide extract prepared by the preparation method described in any one of the contents of the third aspect, including a skin care product made using the Dendrobium officinale polysaccharide extract as raw material for the antioxidant and anti-aging repair of human skin.
[0019] Compared with the prior art, the beneficial effects of this application are:
[0020] The first aspect of the present application provides a lactic acid-based molecular machine, comprising a first functional motif and a second functional motif; the first functional motif and the second functional motif are combined by hydrogen bonds; the first functional motif is a lactic acid molecule, and the second functional motif is at least one of a betaine molecule, a matrine molecule or a L-carnitine molecule; the Dendrobium officinale polysaccharide comprises O-acetyl β-D-glucomannan, and the main chain of the O-acetyl β-D-glucomannan is composed of D-mannose and D-glucose linked by β-1,4 glycosidic bonds; the lactic acid-based molecular machine is used to drive the lactic acid-based molecular machine to recognize and connect with the Dendrobium officinale polysaccharide by the affinity of hydrogen bonds, including driving the lactic acid-based molecular machine to recognize and connect with the β-1,4 glycosidic bonds of the Dendrobium officinale polysaccharide by the affinity of the hydrogen bonds, and the present application drives the lactic acid-based molecular machine to recognize and connect with the β-1,4 glycosidic bonds of the Dendrobium officinale polysaccharide by the affinity of the hydrogen bonds. The intermolecular hydrogen bonds between at least one of the alkali molecules or L-carnitine molecules are combined together to form a lactic acid-based molecular machine. When the lactic acid-based molecular machine of the present application is used to extract Dendrobium officinale polysaccharides, the lactic acid-based molecular machine drives the lactic acid-based molecular machine to recognize and connect with the Dendrobium officinale polysaccharide through the affinity of the hydrogen bonds, including driving the lactic acid-based molecular machine to recognize and connect with the β-1,4 glycosidic bonds of the Dendrobium officinale polysaccharide through the affinity of the hydrogen bonds, thereby improving the transfer rate of the effective ingredients in Dendrobium officinale, while retaining the activity of the active substances, improving the stability of the active substances in the Dendrobium officinale, and dissolving and dissociating the cellulose in the cell wall of Dendrobium officinale, thereby improving the permeability of the cell wall of Dendrobium officinale, improving the solubility of the active components in the Dendrobium officinale cells, and thereby improving the efficiency of extracting Dendrobium officinale polysaccharides.
[0021] The second aspect of the present application provides a method for preparing a lactic acid-based molecular machine as described in the first aspect, comprising the following steps: mixing at least one of betaine, matrine or L-carnitine with lactic acid to obtain a mixed solution, and heating the mixed solution until the viscosity of the mixed solution is 200 mPa•s~500 mPa•s to obtain a lactic acid-based molecular machine; wherein the temperature of the heating treatment is 30℃~60℃; a lactic acid-based molecular machine of a preset viscosity is synthesized by a heating stirring method in which the temperature and duration of the heating treatment are controlled. The molecular machine of the present application can remain stable, clear, transparent and uniform at room temperature, and no subsequent separation is required, thereby simplifying the preparation process of the lactic acid-based molecular machine; in addition, the synthesis process of the lactic acid-based molecular machine of the present application has an atomic economy of 100%, is green and economical, has good biocompatibility, is safe and non-toxic, and has a three-dimensional ordered structure, which is convenient for effectively capturing active substances through intermolecular forces.
[0022] The third aspect of the present application provides a method for preparing a polysaccharide extract of Dendrobium officinale, comprising the following steps: step S100, mixing Dendrobium officinale powder with a lactic acid-based molecular machine solution and then subjecting the mixture to ultrasonic strengthening treatment to obtain a Dendrobium officinale extract; step S200, centrifuging the Dendrobium officinale extract, filtering the supernatant after the centrifugation, and obtaining a polysaccharide extract of Dendrobium officinale; wherein the solute in the lactic acid-based molecular machine solution is the lactic acid-based molecular machine in the first aspect, and / or the lactic acid-based molecular machine obtained by the preparation method in the second aspect; compared with the prior art, since lactic acid-based molecular machines are used to extract Dendrobium officinale polysaccharides, no enzyme is required for catalysis, and the lactic acid-based molecular machines drive the lactic acid-based molecular machines to recognize and connect with the Dendrobium officinale polysaccharides through the affinity of hydrogen bonds, thereby improving the iron The transfer rate of effective ingredients in Dendrobium officinale is 2.35 times that of water extraction and 1.86 times that of cellulose enzymatic hydrolysis. In the lactic acid-based molecular machine system, the polysaccharide compounds can stably exist for 4 months without decomposition, and the stability is relatively good. The lactic acid-based molecular machine can effectively inhibit the growth of microorganisms and prevent the polysaccharide extract from deteriorating. The microbial content of the polysaccharide extract did not exceed the standard when placed in natural light at room temperature for 4 months. At the same time, by coupling ultrasonic enhancement, the dissolution and dissociation of cellulose in the cell wall of Dendrobium officinale can be accelerated, the polysaccharide content is effectively increased, the amount of solvent used is reduced, impurities are reduced, the transfer rate of effective ingredients is increased, the use and residual problems of organic solvents are solved, high-quality and stable production is achieved, and the utilization rate and added value of active substances are improved.
[0023] The fourth aspect of the present application provides an antioxidant and anti-aging application of a Dendrobium officinale polysaccharide extract prepared by a preparation method as described in any one of the third aspects, including skin care products made with the Dendrobium officinale polysaccharide extract as raw material for the antioxidant and anti-aging repair of human skin; since the extracted Dendrobium officinale polysaccharide extract does not need to be separated, the lactic acid-based molecular machines in the polysaccharide extract cooperate with the polysaccharide compounds to be used in skin care products to exert the antioxidant, anti-aging, exfoliating, moisturizing and other effects on human skin. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0025] Figure 1 It is a schematic flow chart of a method for preparing a polysaccharide extract of Dendrobium officinale provided in the present application;
[0026] Figure 2 It is the infrared spectrum of the lactobetaine molecular machine and synthetic monomer of the present application;
[0027] Figure 3 It is a schematic diagram of the thermogravimetric curve of the lactic acid betaine molecular machine and synthetic monomer of the present application;
[0028] Figure 4 It is a quantum chemical calculation analysis diagram of the lactic acid betaine molecular machine A1 of the present application, wherein (a) is a structural optimization diagram of the lactic acid betaine molecular machine; (b) is a surface electrostatic potential analysis diagram of the lactic acid betaine molecular machine; (c) is an interaction region indicator function analysis diagram of the lactic acid betaine molecular machine;
[0029] Figure 5 This is a schematic diagram of the change in polysaccharide content of the Dendrobium officinale polysaccharide extract at different storage times under natural light at room temperature according to the present application;
[0030] Figure 6 This is a schematic diagram of the DPPH free radical scavenging test of the Dendrobium officinale polysaccharide extract (lactic acid betaine molecular machine) of the present application;
[0031] Figure 7 A schematic diagram of a hydroxyl radical scavenging test of the Dendrobium officinale polysaccharide extract (lactic acid betaine molecular machine) of the present application;
[0032] Figure 8 A schematic diagram of the effect of the Dendrobium officinale polysaccharide extract (lactic acid betaine molecular machine) of the present application on the activity of human skin fibroblasts;
[0033] Fig. 9 A schematic diagram of the effect of the Dendrobium officinale polysaccharide extract (lactic acid betaine molecular machine) of the present application on the content of human type I collagen;
[0034] Fig.10 A schematic diagram of the effect of the Dendrobium officinale polysaccharide extract (lactic acid betaine molecular machine) of the present application on the relative content of MMP-1;
[0035] Fig.11 This is a schematic diagram of the effect of the Dendrobium officinale polysaccharide extract (lactic acid betaine molecular machine) of the present application on the relative content of MMP-3. DETAILED DESCRIPTION
[0036] In order to make the technical problems, technical solutions and beneficial effects to be solved by the present application more clearly understood, the present application is further described in detail below in conjunction with the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present application and are not used to limit the present application.
[0037] In this application, the term "and / or" describes the association relationship of associated objects, indicating that there may be three relationships. For example, A and / or B can mean: A exists alone, A and B exist at the same time, and B exists alone. A and B can be singular or plural. The character " / " generally indicates that the associated objects are in an "or" relationship.
[0038] In the present application, "at least one" means one or more, and "more than one" means two or more. "At least one of the following" or similar expressions refers to any combination of these items, including any combination of single or plural items. For example, "at least one of a, b, or c", or "at least one of a, b, and c", can all mean: a, b, c, ab (i.e. a and b), ac, bc, or abc, where a, b, c can be single or multiple, respectively.
[0039] It should be understood that in various embodiments of the present application, the size of the sequence number of each process described above does not mean the order of execution, some or all of the steps can be executed in parallel or in sequence, and the execution order of each process should be determined by its function and internal logic, and should not constitute any limitation on the implementation process of the implementation regulations of this application. The terms used in the embodiments of the present application are only for the purpose of describing specific implementation regulations, and are not intended to limit this application. The singular forms of "a", "said" and "the" used in the implementation regulations of this application and the attached claims are also intended to include plural forms, unless the context clearly indicates other meanings.
[0040] The weight of the relevant components mentioned in the embodiment description of the present application can not only refer to the specific content of each component, but also represent the proportional relationship between the weights of the components. Therefore, as long as the content of the relevant components is proportionally enlarged or reduced according to the embodiment description of the present application, it is within the scope disclosed in the embodiment description of the present application. Specifically, the mass described in the embodiment description of the present application can be a mass unit known in the chemical industry such as μg, mg, g, kg, etc.
[0041] The terms "first" and "second" are used only for descriptive purposes to distinguish objects such as substances from each other, and should not be understood as indicating or implying relative importance or implicitly indicating the number of technical features indicated. For example, without departing from the scope of the implementation regulations of this application, the first XX may also be referred to as the second XX, and similarly, the second XX may also be referred to as the first XX. Therefore, the features defined as "first" and "second" may explicitly or implicitly include one or more of the features.
[0042] In order to facilitate the understanding of the present invention, the present invention will be described more comprehensively and meticulously below in conjunction with the accompanying drawings and preferred embodiments of the present invention, but the protection scope of the present invention is not limited to the following specific embodiments.
[0043] Unless otherwise defined, all professional terms used below have the same meanings as those generally understood by those skilled in the art. The professional terms used herein are only for the purpose of describing specific embodiments and are not intended to limit the scope of protection of the present invention.
[0044] Unless otherwise specified, various raw materials, reagents, instruments and equipment used in the present invention can be purchased from the market or prepared by existing methods.
[0045] Molecular machines refer to machines composed of molecular-scale materials that can perform certain functions. They have the characteristics of small size, diversity, self-assembly, adaptability, wide polarity range, and strong designability. Molecular machines combine the above components together through intermolecular interactions (hydrogen bonds, van der Waals forces, electrostatic attraction, etc.) and have clear microscopic structures and macroscopic properties.
[0046] The first aspect of the embodiment of the present application provides a lactic acid-based molecular machine, including a first functional unit and a second functional unit; the first functional unit and the second functional unit are combined by hydrogen bonds; the first functional unit is a lactic acid molecule, and the second functional unit is at least one of a betaine molecule, a matrine molecule or a L-carnitine molecule; wherein, the Dendrobium officinale polysaccharide includes O-acetyl β-D-glucomannan, and the main chain of the O-acetyl β-D-glucomannan is composed of D-mannose and D-glucose linked by β-1,4 glycosidic bonds; the lactic acid-based molecular machine is used to drive the lactic acid-based molecular machine to recognize and connect with the Dendrobium officinale polysaccharide through the affinity of hydrogen bonds, including driving the lactic acid-based molecular machine to bind to the β-1,4 glycosidic bond of the Dendrobium officinale polysaccharide through the affinity of hydrogen bonds, and when the second functional unit is a betaine molecule, the molecular structure of the molecular machine is CH3CH(OH)COO-H-OOCCH2N(CH3)3.
[0047] The present invention forms a lactic acid-based molecular machine by combining lactic acid molecules with at least one of betaine molecules, matrine molecules or L-carnitine molecules through hydrogen bonds of specific bond lengths of intermolecular interactions. Since the hydrogen bond lengths formed between the hydroxyl groups of lactic acid molecules and the carbonyl groups of at least one of betaine molecules, matrine molecules or L-carnitine molecules in the lactic acid-based molecular machine of the present invention are smaller than the van der Waals radius, the stability of the lactic acid-based molecular machine is relatively high. The lactic acid-based molecular machine of the present invention is effective in extracting iron skin stone. When extracting Dendrobium officinale polysaccharide, the lactic acid-based molecular machine drives the lactic acid-based molecular machine to recognize and connect with Dendrobium officinale polysaccharide through the affinity of hydrogen bonds, thereby improving the transfer rate of the effective ingredients in Dendrobium officinale, while retaining the activity of the active substances, improving the stability of the active substances in Dendrobium officinale, and dissolving and dissociating the cellulose in the cell wall of Dendrobium officinale, thereby improving the permeability of the cell wall of Dendrobium officinale, increasing the solubility of the active components in the cells of Dendrobium officinale, and thus improving the efficiency of extracting Dendrobium officinale polysaccharide.
[0048] In some embodiments, the hydrogen bond length is 1 Å~2 Å, where the hydrogen bond length is the bond length between the hydrogen (H) atom and the oxygen (O) atom in the betaine molecule. The shorter bond length ensures that the first functional unit and the second functional unit have a greater interaction force and are not easily destroyed, and the molecular machine can remain stable, which is conducive to the combination of the molecular machine and Dendrobium officinale polysaccharide.
[0049] In some embodiments, the molar ratio of the first functional unit to the second functional unit is 1: (0.25-4), and the molar ratio range of 1: (0.25-4) improves the effect of the lactic acid-based molecular machine in extracting Dendrobium officinale polysaccharides. Furthermore, the yield of the Dendrobium officinale polysaccharide extract prepared by the lactic acid-based molecular machine formed by the molar ratio of the first functional unit to the second functional unit is 1:1 is the highest.
[0050] In some embodiments, Dendrobium officinale polysaccharide is a polysaccharide structure formed by multiple monosaccharides including glucose, mannose and galactose connected by glycosidic bonds. The lactic acid-based molecular machine drives the lactic acid-based molecular machine to combine with various monosaccharides of Dendrobium officinale polysaccharide through the affinity of hydrogen bonds, thereby improving the transfer rate of effective ingredients in Dendrobium officinale, improving the yield of Dendrobium officinale polysaccharide extract prepared based on lactic acid-based molecular machines, and thereby improving the efficiency of extracting Dendrobium officinale polysaccharide.
[0051] The second aspect of the embodiment of the present application provides a method for preparing a lactic acid-based molecular machine as described in the first aspect, comprising the following steps: mixing at least one of betaine, matrine or L-carnitine with lactic acid to obtain a mixed solution, and heating the mixed solution until the viscosity of the mixed solution is 200 mPa•s~500 mPa•s; wherein the heating treatment temperature is 30℃~60℃.
[0052] It can be understood that the molar ratio of the first functional motif to the second functional motif is 1: (0.25~4), and the molar ratio of the first functional motif to the second functional motif is different, and the internal structure of the formed molecular machine is different. Therefore, the effect of the lactic acid-based molecular machine driving the lactic acid-based molecular machine to recognize and connect with the Dendrobium officinale polysaccharide through the affinity of hydrogen bonds is different, and the polysaccharide yield effect used to prepare the Dendrobium officinale polysaccharide extract is also different. Exemplarily, the molar ratio of betaine to lactic acid used for mixing is any one of 1: 1, 1: 2, 1: 3, and 1: 4. The prepared lactic acid-based molecular machine improves the stability of the active substances in the Dendrobium officinale, improves the permeability of the cell wall of the Dendrobium officinale, improves the solubility of the active components in the cells of the Dendrobium officinale, and improves the transfer rate of the effective ingredients in the Dendrobium officinale, thereby improving the efficiency of extracting the Dendrobium officinale polysaccharide. Since no enzyme is required for catalytic extraction, the cost of extracting the Dendrobium officinale polysaccharide is also reduced. Preferably, the molar ratio of betaine to lactic acid used for mixing is 1:1. In this preferred case, the prepared lactic acid-based molecular machine further improves the solubility of active components in Dendrobium officinale cells, further improves the transfer rate of effective ingredients in Dendrobium officinale, thereby further improving the efficiency of extracting Dendrobium officinale polysaccharides and reducing the cost of extracting Dendrobium officinale polysaccharides. Therefore, the polysaccharide yield of the prepared Dendrobium officinale polysaccharide extract is higher, and the performance of extracting Dendrobium officinale polysaccharides is better.
[0053] The present application synthesizes a lactic acid-based molecular machine by a heating stirring method in which the temperature and duration of the heating treatment are controlled. The molecular machine of the present application can remain stable at room temperature, clear, transparent and uniform, and does not need to be separated subsequently, thereby simplifying the preparation process of the lactic acid-based molecular machine. In addition, the synthesis process of the lactic acid-based molecular machine of the present application has 100% atomic economy, is green and economical, has good biocompatibility, is safe and non-toxic, and has a three-dimensional ordered structure, which facilitates the effective capture of active substances through intermolecular forces.
[0054] In some embodiments, at least one of betaine, matrine or L-carnitine is mixed with lactic acid and then heated to obtain a lactic acid-based molecular machine, including: mixing lactic acid and at least one of betaine, matrine or L-carnitine to obtain a mixed solution, heating the mixed solution to 30°C~60°C, and stirring the mixture at 30°C~60°C for 3 h~8 h until the viscosity of the mixed solution is 200 mPa•s~500 mPa•s, to obtain a lactic acid-based molecular machine; adding water to the lactic acid-based molecular machine to dilute it to obtain a lactic acid-based molecular machine solution, thereby optimizing the process for preparing the lactic acid-based molecular machine.
[0055] like Figure 1 As shown, the third aspect of the embodiment of the present application provides a method for preparing a polysaccharide extract of Dendrobium officinale, comprising the following steps:
[0056] Step S100, mixing the Dendrobium officinale powder and the lactic acid-based molecular machine solution and then performing ultrasonic strengthening treatment to obtain a Dendrobium officinale extract;
[0057] Step S200, centrifuging the Dendrobium officinale extract, filtering the supernatant after the centrifugation, and obtaining the Dendrobium officinale polysaccharide extract;
[0058] Wherein, the solute in the lactic acid-based molecular machine solution is the lactic acid-based molecular machine in the first aspect, and / or, is the lactic acid-based molecular machine prepared by the preparation method in the second aspect.
[0059] Compared with the prior art, since lactic acid-based molecular machines are used to extract Dendrobium officinale polysaccharides, no enzyme is needed for catalysis. The lactic acid-based molecular machines drive the lactic acid-based molecular machines to recognize and connect with Dendrobium officinale polysaccharides through the affinity of hydrogen bonds, thereby improving the transfer rate of effective ingredients in Dendrobium officinale. The extraction effect of polysaccharides in the Dendrobium officinale extract of the present application is 2.35 times that of water extraction and 1.86 times that of cellulose enzymatic hydrolysis; in the lactic acid-based molecular machine system, polysaccharides can stably exist for 4 months without decomposition, and the stability is The lactic acid-based molecular machine can effectively inhibit the growth of microorganisms and prevent the polysaccharide extract from deteriorating. The microbial contents of the polysaccharide extract did not exceed the standard when placed in natural light at room temperature for 4 months. At the same time, through the coupling of ultrasonic enhancement, the dissolution and dissociation of cellulose in the cell wall of Dendrobium officinale can be accelerated, the polysaccharide content is effectively increased, the solvent usage is reduced, impurities are reduced, the transfer rate of effective ingredients is increased, the use and residual problems of organic solvents are solved, high-quality and stable production is achieved, and the utilization rate and added value of active substances are improved.
[0060] In some embodiments, pre-treating Dendrobium officinale to obtain Dendrobium officinale powder includes: washing Dendrobium officinale with clean water; freeze-drying Dendrobium officinale at a preset drying temperature; crushing and sieving the dried Dendrobium officinale and storing it at low temperature, wherein the freeze-drying time is 1h~6h, the preset drying temperature is -20℃~70℃, the crushing and sieving is 60 mesh sieving, the particle size of the sieved Dendrobium officinale powder is not more than 0.3mm, and the temperature of low temperature storage is -10℃~20℃, thereby optimizing the pre-treatment process of Dendrobium officinale and preserving the active substances or effective ingredients in Dendrobium officinale. The particle size of Dendrobium officinale powder is not more than 0.3mm, that is, when the particle size of Dendrobium officinale powder is less than or equal to 0.3mm, it can have more contact area with Dendrobium officinale polysaccharides, thereby improving the extraction efficiency of Dendrobium officinale polysaccharides.
[0061] In some embodiments, the mass volume ratio of the Dendrobium officinale powder and the lactic acid-based molecular machine solution in step S100 is 1: 5 g / mL~70 g / mL; that is, 1 g of Dendrobium officinale powder is mixed with 5 mL~70 mL of lactic acid-based molecular machine solution to effectively extract polysaccharides in Dendrobium officinale, and the lactic acid-based molecular machine solution is less than 5 mL. The polysaccharides in Dendrobium officinale cannot be fully extracted within a certain period of time, and the lactic acid-based molecular machine solution is greater than 70 mL. There is no obvious effect on improving the efficiency of polysaccharides in Dendrobium officinale;
[0062] In some embodiments, the concentration of the lactic acid-based molecular machine solution in step S100 is 5 wt% to 80 wt%; that is, the concentration of the solution after the lactic acid-based molecular machine is diluted with water is 5 wt% to 80 wt%, so as to improve the efficiency of extracting polysaccharides from Dendrobium officinale. Furthermore, the water is pure water or ultrapure water to reduce the influence of impurities on the extraction.
[0063] In some embodiments, the parameters of the ultrasonic enhanced treatment in step S100 are: the ultrasonic enhanced treatment temperature is 30°C~80°C, the ultrasonic enhanced treatment time is 0.5 h~2 h, and the ultrasonic power is 100 W~500 W; the ultrasonic enhanced treatment parameters in this embodiment can more effectively extract the polysaccharides from Dendrobium officinale. Due to the strong vibration generated by the ultrasonic wave in the ultrasonic extraction process, the structure and biological activity of the active ingredients can be kept unchanged while the extraction time is reduced, and the biologically active substances can be obtained efficiently, cheaply and pollution-free, thereby realizing the green and efficient extraction of the active substances of Dendrobium officinale.
[0064] In some embodiments, after step S100 and before step S200, the method further includes: adjusting the pH value of the extract of Dendrobium officinale to a preset pH value; adjusting the pH value of the extract of Dendrobium officinale to the preset pH value can separate the lactic acid-based molecular machine from the polysaccharide of Dendrobium officinale, and improve the purity of the polysaccharide of Dendrobium officinale. Further, the preset pH value is greater than 6.5 and less than 7.0; the preset pH value can more effectively separate the lactic acid-based molecular machine from the polysaccharide of Dendrobium officinale within the scope of this embodiment, and further improve the purity of the polysaccharide of Dendrobium officinale.
[0065] In some embodiments, the parameters of the centrifugal treatment in step S200 are: the centrifugal treatment speed is 6000 r / min~12000 r / min, the centrifugal treatment time is 5 min~15 min, the centrifugal treatment filter membrane is an organic phase filter membrane, and the pore size of the organic phase filter membrane is not more than 0.45 μm; using the centrifugal treatment parameters in this embodiment for centrifugal treatment can effectively remove impurities and increase the concentration of the Dendrobium officinale polysaccharide extract.
[0066] The fourth aspect of the embodiments of the present application provides an antioxidant and anti-aging application of a Dendrobium officinale polysaccharide extract prepared by a preparation method as described in any one of the fourth aspects, including skin care products made from the Dendrobium officinale polysaccharide extract as raw material for the antioxidant and anti-aging repair of human skin.
[0067] The Dendrobium officinale polysaccharide extract for antioxidant and anti-aging applications of the present application does not need to be separated, and the lactic acid-based molecular machinery in the polysaccharide extract cooperates with the polysaccharide compounds to be applied in skin care products, having antioxidant, anti-aging, exfoliating, moisturizing and other effects on human skin.
[0068] In some embodiments, the Dendrobium officinale polysaccharide extract is also used for cytotoxicity testing, human skin patch testing or nine routine cosmetic tests, expanding the application scenarios of the Dendrobium officinale polysaccharide extract.
[0069] In order to enable the above implementation details and operations of the present application to be clearly understood by those skilled in the art, as well as the significant embodiment of the improved performance of the molecular machine, the preparation method of the extract, and the antioxidant and anti-aging applications of the embodiments of the present application, the above technical scheme is illustrated by multiple embodiments below.
[0070] Preparation Example 1:
[0071] A method for preparing a lactic acid-based molecular machine comprises mixing betaine and lactic acid in a molar ratio of 1:1 to obtain a mixed solution; heating the mixed solution until the viscosity of the mixed solution is 325 mPa•s to obtain a viscous liquid lactic acid-based molecular machine A1;
[0072] The heating temperature is 50°C and the heating time is 6 hours.
[0073] Preparation Example 2:
[0074] A method for preparing a lactic acid-based molecular machine, wherein the molar ratio of betaine to lactic acid is adjusted to 1:2, the viscosity of the mixed solution is 308 mPa•s, and the remaining steps and parameters are the same as those in Preparation Example 1, to obtain a lactic acid-based molecular machine A2.
[0075] Preparation Example 3:
[0076] A method for preparing a lactic acid-based molecular machine, wherein the molar ratio of betaine to lactic acid is adjusted to 1:3, the viscosity of the mixed solution is 280 mPa•s, and the remaining steps and parameters are the same as those in Preparation Example 1, to obtain a lactic acid-based molecular machine A3.
[0077] Preparation Example 4:
[0078] A method for preparing a lactic acid-based molecular machine, wherein the molar ratio of betaine to lactic acid is adjusted to 1:4, the viscosity of the mixed solution is 271 mPa•s, and the remaining steps and parameters are the same as those in Preparation Example 1, to obtain a lactic acid-based molecular machine A4.
[0079] Preparation Example 5:
[0080] A method for preparing a lactic acid-based molecular machine, wherein betaine is replaced by matrine, and the remaining steps and parameters are the same as those in Preparation Example 1, to obtain a lactic acid-based molecular machine A5.
[0081] Preparation Example 6:
[0082] A method for preparing a lactic acid-based molecular machine, wherein betaine is replaced by L-carnitine, and the remaining steps and parameters are the same as those in Preparation Example 1, to obtain a lactic acid-based molecular machine A6.
[0083] Comparative Preparation Example 1:
[0084] A method for preparing a lactic acid-based molecular machine, wherein betaine is replaced by choline chloride, and the remaining parameters are the same as those in Preparation Example 1, to obtain a lactic acid-based molecular machine DA1.
[0085] Test Example 1: Infrared spectroscopy analysis of lactic acid-based molecular machines
[0086] The shift and broadening of the main functional groups of the lactic acid betaine molecular machines A1 to A4, the synthetic monomer betaine and lactic acid were analyzed by infrared spectrometer to determine whether the lactic acid-based molecular machine was successfully synthesized.
[0087] The specific operation method is to mix the lactic acid-based molecular machines A1 to A4, betaine, and lactic acid samples with KBr in a ratio of 1:50 and press them into tablets. The wavelength scanning range is 500 cm -1 ~4000 cm -1 .like Figure 2 As shown, Figure 2 The infrared spectra of lactic acid betaine molecular machines A1 to A4, synthetic monomer betaine and lactic acid, where 1:1 represents lactic acid betaine molecular machine A1, 1:2 represents lactic acid betaine molecular machine A2, 1:3 represents lactic acid betaine molecular machine A3, and 1:4 represents lactic acid betaine molecular machine A4. For lactic acid, at 3450 cm -1 The broad absorption peak around 1680 cm -1 There are broad absorption peaks on the left and right, which are caused by the carbonyl group in lactic acid. For betaine, at 3300 cm -1 and 1620 cm -1 Two absorption peaks appeared, confirming the presence of hydroxyl and amino groups in betaine. For lactic acid betaine molecular machines A1 to A4, the absorption peaks at about 3635 cm -1 ~3097 cm -1 、1784 cm -1 ~1682 cm -1,1677cm -1 ~1525 cm -1 At the 40° point, three strong and broad absorption peaks appeared, and these three peaks were offset relative to the respective characteristic peaks of the monomers, indicating the existence of -COOH···NH hydrogen bonds. The formation of hydrogen bonds leads to a decrease in vibration frequency and a broadening of the spectral band, causing the characteristic peaks of the two components to shift, broaden, and even overlap.
[0088] Test Example 2: Thermogravimetric curve analysis of lactic acid-based molecular machines
[0089] The thermal stability and thermal decomposition of lactic acid betaine molecular machines A1 to A4, synthetic monomer betaine and lactic acid were analyzed using a Mettler TGA2 thermogravimetric analyzer. The experimental samples of lactic acid betaine molecular machines A1 to A4, betaine and lactic acid were heated at a rate of 10 ℃ / min from room temperature 25 ℃ to 600 ℃ under nitrogen protection, and the thermogravimetric analysis (TGA) curve was drawn to obtain the decomposition temperature of the corresponding samples. Figure 3 As shown, Figure 3 Schematic diagram of thermogravimetric curves of lactic acid betaine molecular machines A1 to A4, synthetic monomer betaine and lactic acid, wherein 1:1 represents lactic acid betaine molecular machine A1, 1:2 represents lactic acid betaine molecular machine A2, 1:3 represents lactic acid betaine molecular machine A3, and 1:4 represents lactic acid betaine molecular machine A4. Figure 3 It can be seen that the initial decomposition temperature of lactobetaine molecular machines A1 to A4 is between their pure raw material components, and the weight reduction gradient is slowed down. The thermal stability of lactobetaine molecular machines is improved to a certain extent compared with monomeric lactic acid.
[0090] Test Example 3: Quantum Chemical Computational Analysis of Lactic Acid-Based Molecular Machines
[0091] like Figure 4 As shown, Figure 4 The quantum chemical calculation analysis diagram of the lactobetaine molecular machine A1, where (a) is the structure optimization diagram; (b) is the surface electrostatic potential (ESP) potential analysis diagram; (c) is the interaction region indicator function (IRI) analysis diagram;
[0092] like Figure 4As shown in (a), the geometry optimization and frequency calculation of the lactic acid betaine molecular machine converged, and no imaginary frequency was found, indicating that the current structure is at the local minimum point of the potential energy surface and can exist stably. The hydroxyl group of lactic acid and the carbonyl group of betaine interact with each other through hydrogen bonds. In this embodiment, the hydrogen bond length is 1.41046Å, and the group distance between lactic acid and betaine in the lactic acid betaine molecular machine is less than the van der Waals radius. Based on the optimized structure of the lactic acid betaine molecular machine, the interaction groups between betaine and lactic acid are mutually confirmed by infrared spectroscopy analysis.
[0093] like Figure 4 As shown in (b), ESP was used to qualitatively analyze the formation mechanism of the lactic acid betaine molecular machine. The carboxyl region of betaine is electronegative, and a large area surrounding the nitrogen atom is electronegative. The hydroxyl region of lactic acid is electronegative, and the carboxyl region is electronegative. After the lactic acid betaine molecular machine is formed, the electronegative region of betaine and the electronegative region of lactic acid attract each other to form a stable molecular machine structure. The interaction region indicator function (IRI) is used to characterize the van der Waals force, hydrogen bond, and steric repulsion of the molecule, such as Figure 4 As shown in (c), in the interaction relationship, blue represents strong attractive interactions such as hydrogen bonds, and red represents strong steric hindrance. The stronger the steric hindrance, the more difficult it is for the atoms in the corresponding two regions to attract each other; the large green transition area represents the van der Waals weak interaction force. Since there is a large green interaction force area between betaine and lactic acid, it indicates that there is a van der Waals force between betaine and lactic acid, and there is a small blue disc between the hydroxyl and carboxyl groups, indicating that there is also a strong hydrogen bond interaction between betaine and lactic acid.
[0094] Embodiment 1:
[0095] (1) Using lactic acid-based molecular machine A1 as solute and ultrapure water as solvent, a lactic acid-based molecular machine solution with a concentration of 10 wt% was prepared.
[0096] (2) Adding the powder of Dendrobium officinale to the lactic acid-based molecular machine solution, and subjecting it to ultrasonic enhanced treatment to obtain an extract.
[0097] Among them, the mass volume ratio of Dendrobium officinale powder and lactic acid-based molecular machine solution is 1g:50mL; the parameters of ultrasonic enhanced treatment are: extraction temperature is 60°C, extraction time is 1h, and ultrasonic power is 300W; the particle size of Dendrobium officinale powder is not more than 0.3mm.
[0098] (3) The pH value of the Dendrobium officinale extract was adjusted to 6.6, and the extract was centrifuged at a speed of 10,000 r / min for 15 min. The supernatant after centrifugation was filtered using a 0.45 μm organic phase filter membrane to obtain a Dendrobium officinale polysaccharide extract based on the lactobetaine molecular machine, which was named extract B1.
[0099] Embodiment 2:
[0100] The concentration of the lactobetaine molecular machine solution in step (1) of Example 1 was adjusted to 20 wt %, the pH value of the Dendrobium officinale extract was adjusted to 6.7, and the remaining steps and parameters were the same as in Example 1 to obtain extract B2.
[0101] Example 3: The concentration of the lactic acid betaine molecular machine solution in step (1) of Example 1 was adjusted to 30wt%, the pH value of the Dendrobium officinale extract was adjusted to 6.75, and the remaining steps and parameters were the same as in Example 1 to obtain extract B3.
[0102] Example 4: The concentration of the lactic acid betaine molecular machine solution in step (1) of Example 1 was adjusted to 40wt%, the pH value of the Dendrobium officinale extract was adjusted to 6.8, and the remaining steps and parameters were the same as in Example 1 to obtain extract B4.
[0103] Example 5: The concentration of the lactic acid betaine molecular machine solution in step (1) of Example 1 was adjusted to 50wt%, the pH value of the Dendrobium officinale extract was adjusted to 6.9, and the remaining steps and parameters were the same as in Example 1 to obtain extract B5.
[0104] Example 6: The solute in step (1) of Example 4 was replaced by lactic acid-based molecular machine A5 from lactic acid-based molecular machine A1, and the remaining steps and parameters were the same as Example 4 to obtain extract B6.
[0105] Example 7: The solute in step (1) of Example 4 was replaced by lactic acid-based molecular machine A6 from lactic acid-based molecular machine A1, and the remaining steps and parameters were the same as those of Example 4, to obtain extract B7.
[0106] Comparative Example 1: The solute in step (1) of Example 4 was replaced by lactic acid-based molecular machine A1 with lactic acid-based molecular machine DA1, and the remaining steps and parameters were the same as Example 4 to obtain an extract DB1.
[0107] Comparative Example 2:
[0108] A preparation method of a Dendrobium officinale polysaccharide extract (water), comprising the following specific steps:
[0109] (1) Preparation of water extract: Adding Dendrobium officinale powder to ultrapure water and subjecting to ultrasonic enhanced treatment to obtain a water extract, wherein the mass volume ratio of Dendrobium officinale powder to water is 1 g:50 mL, and the parameters of the ultrasonic enhanced treatment are: extraction temperature is 60°C, extraction time is 1 h, and ultrasonic power is 300 W; the particle size of the Dendrobium officinale powder is not greater than 0.3 mm.
[0110] (2) Extraction: The extract was centrifuged at 10,000 r / min for 15 min, and the supernatant was filtered using a 0.45 μm organic phase filter to remove excess impurities, thereby obtaining an extract DB2.
[0111] Comparative Example 3:
[0112] A preparation method of a Dendrobium officinale polysaccharide extract (cellulase), comprising the following specific steps:
[0113] (1) Preparation of enzymatic hydrolysis solution: Dissolve cellulase in citric acid buffer to obtain enzymatic hydrolysis solution; the concentration of cellulase and citric acid is 1 mg / ml.
[0114] (2) Extraction: Add the powder of Dendrobium officinale to the enzymatic hydrolysis solution for a period of time, and then heat to inactivate the enzyme to finally obtain the cellulase extract; the mass volume ratio of Dendrobium officinale powder to the enzymatic hydrolysis solution is 1g:50mL, the enzymatic hydrolysis time is 2h, the enzymatic hydrolysis temperature is 40℃, the heating enzyme inactivation temperature is 80℃, and the corresponding time is 25min. The above extract is centrifuged, wherein the centrifugation parameter is 10000r / min, the centrifugation is 15min, and the upper clear liquid is filtered, and the filter membrane used for filtration is a 0.45μm organic phase filter membrane to remove excess impurities and obtain the extract DB3.
[0115] Test Example 4: Test of different concentrations of lactic acid-based molecular machine solutions and different types of extracts on the polysaccharide yield of the extract
[0116] The polysaccharide yield of each extract prepared based on the above 7 examples and 3 comparative examples was tested according to the following method:
[0117] 50 mg of the extracts B1 to B7 prepared in the above 7 examples and the extracts DB1 to DB3 prepared in the 3 comparative examples were weighed into 250 mL glass test tubes, and diluted to 250 mL with distilled water.
[0118] Then, 1 mL of each diluted extract was transferred to a 10 mL glass test tube, and 1 mL of distilled water was added to make the volume 2 mL. Then, 1 mL of 5% volume concentration phenol aqueous solution and 5 mL of 98% volume concentration concentrated sulfuric acid were added to each 10 mL glass test tube.
[0119] Then, each 10 mL glass test tube was shaken and allowed to stand for 30 minutes, and the absorbance was measured at 490 nm by an ultraviolet spectrophotometer, and analyzed and calculated by a glucose standard curve to obtain the polysaccharide yield corresponding to each extract. The polysaccharide yield is the ratio of the amount of polysaccharide actually obtained during the extraction process to the total polysaccharide in the raw material Dendrobium officinale powder, generally expressed as a percentage.
[0120] The calculation formula for the yield of polysaccharides is:
[0121] Polysaccharide yield = (actual amount of polysaccharide obtained / total amount of raw materials input) × 100%.
[0122] Among them, the actual amount of polysaccharides obtained is the weight of polysaccharides in the Dendrobium officinale polysaccharide extract (i.e., the extract), the total input amount in the raw materials is the total weight of the raw material Dendrobium officinale powder put into the extraction, and the polysaccharide yield is the yield indicator of the extracted polysaccharides.
[0123] The polysaccharide yields of the extracts obtained from the seven embodiments and three comparative examples are shown in Table 1. The polysaccharide extraction effects of lactic acid-based molecular machines of different combinations and concentrations are better than those of traditional water extraction and enzymatic hydrolysis processes. Among them, the lactic acid betaine molecular machine has the best extraction effect. When the concentration is 40wt%, the extraction efficiency is the highest, up to 197.6mg / g, which is 2.35 times that of the water extraction method (84.2mg / g) and 1.86 times that of the cellulose enzymatic hydrolysis method (106.2mg / g). It has broad market application prospects. Lactic acid-based molecular machines not only have higher extraction efficiency, but are also green solvents with anti-inflammatory, moisturizing, anti-wrinkle and other effects. Their use can reduce waste, simplify process processing and reduce costs:
[0124] .
[0125] Example 8: Take the lactic acid betaine molecular machine solution with a concentration of 40wt% in Example 4, adjust the extraction temperature of the ultrasonic enhanced treatment to 30°C, and the remaining steps and parameters are the same as Example 4 to obtain extract B8.
[0126] Example 9: Take the lactic acid betaine molecular machine solution with a concentration of 40wt% of Example 4, adjust the extraction temperature of the ultrasonic enhanced treatment to 40°C, and the remaining steps and parameters are the same as Example 4 to obtain extract B9.
[0127] Example 10: Take the lactic acid betaine molecular machine solution with a concentration of 40wt% in Example 4, adjust the extraction temperature of the ultrasonic enhanced treatment to 50°C, and the remaining steps and parameters are the same as Example 4 to obtain an extract B10.
[0128] Example 11: Take the lactic acid betaine molecular machine solution with a concentration of 40wt% in Example 4, adjust the extraction temperature of the ultrasonic enhanced treatment to 70°C, and the remaining steps and parameters are the same as Example 4 to obtain extract B11.
[0129] Test Example 5: Test on the effect of different ultrasonic enhanced extraction temperatures on the polysaccharide yield of the extract
[0130] Based on the extracts B6, B8 to B11 prepared in Examples 4, 8 to 11 above, the polysaccharide yields of the extracts were tested respectively. The polysaccharide yields of the extracts prepared at different extraction temperatures are shown in Table 2. It can be found that as the temperature increases, the polysaccharide yield gradually increases, but at a higher extraction temperature of 70°C, the yield decreases slightly:
[0131] .
[0132] Example 12: Take the lactic acid betaine molecular machine solution with a concentration of 40wt% in Example 4, adjust the extraction time of ultrasonic enhanced treatment to 0.25 h, and the remaining steps and parameters are the same as Example 4 to obtain extract B12.
[0133] Example 13: Take the lactic acid betaine molecular machine solution with a concentration of 40wt% in Example 4, adjust the extraction time of ultrasonic enhanced treatment to 0.5 h, and the remaining steps and parameters are the same as Example 4 to obtain extract B13.
[0134] Example 14: Take the lactic acid betaine molecular machine solution with a concentration of 40wt% in Example 4, adjust the extraction time of ultrasonic enhanced treatment to 1.5 h, and the remaining steps and parameters are the same as Example 4 to obtain extract B14.
[0135] Example 15: Take the lactic acid betaine molecular machine solution with a concentration of 40wt% in Example 4, adjust the extraction time of ultrasonic enhanced treatment to 2.0 h, and the remaining steps and parameters are the same as Example 4 to obtain extract B15.
[0136] Test Example 6: Test on the effect of different ultrasonic enhanced extraction time on the polysaccharide yield of the extract
[0137] Based on the extracts B6, B13 to B15 prepared in the above Examples 4, 13 to 15, the polysaccharide yields of the extracts were tested respectively. The polysaccharide yields of the extracts prepared at different extraction times are shown in Table 3. It can be found that the polysaccharide yield gradually increased within 1 hour, but in a longer extraction time, the polysaccharide yield remained basically unchanged or even slightly decreased. This is because the extraction time is too long and the extraction reaches the limit. As time gradually increases, the local high temperature of ultrasound causes some compounds to begin to decompose:
[0138] .
[0139] Test Example 7: Test on the polysaccharide yield of the extract at different storage times under natural light at room temperature
[0140] The extract B4 obtained by the lactic acid betaine molecular machine solution in Example 4 with a mass concentration of 40wt%, an ultrasonic enhanced extraction temperature of 60°C, and an ultrasonic enhanced extraction time of 1h was placed at room temperature under natural light. After 7 days, 15 days, 30 days, 60 days, and 120 days, the polysaccharide concentration in the extract B4 sample was tested respectively. The test results are as follows Figure 5 As shown: Figure 5 The figure is a schematic diagram of the change of polysaccharide content of extract B4 at different storage time under natural light at room temperature. As the storage time starts from 7 days to 120 days, the polysaccharide concentration of extract B4 remains basically unchanged, with a slight decrease. This shows that polysaccharide compounds can exist stably in the lactobetaine molecular machine system and will not decompose within 4 months, with good stability.
[0141] Test Example 8: Effects of different storage times at room temperature and under natural light on the content of microorganisms in the extract
[0142] According to the "Microbiological Testing Method" of the "Safety Technical Specifications for Cosmetics" (2015 Edition), the extract B4 prepared in Example 4 was placed under natural light at room temperature. After 7 days, 15 days, 30 days, 60 days and 120 days, the total number of bacteria, total number of molds / yeasts, Staphylococcus aureus, heat-resistant coliform bacteria, and Pseudomonas aeruginosa were tested for the extract B4 samples. The test results are shown in Table 4. The content of each microorganism complies with the "Safety Technical Specifications for Cosmetics" in different time periods and does not exceed the standard. This shows that the lactobetaine molecular machine can effectively inhibit the growth of microorganisms and prevent the polysaccharide extract from deteriorating:
[0143] .
[0144] Test Example 9: DPPH free radical scavenging test of the extract
[0145] The extract B4 obtained under the optimal extraction process conditions of Example 4 was tested for scavenging DPPH free radicals according to the following method.
[0146] Set up sample tubes (T), sample background tubes (T0), DPPH tubes (C) and solvent background tubes (C0). For each sample tube (T) of the tested concentration of extract B4, three parallel tubes should be set up, and extract solutions of different tested mass concentrations (0.0625 mg / ml, 0.125 mg / ml, 0.25 mg / ml, 0.5 mg / ml, 1 mg / ml, 2 mg / ml) should be prepared respectively. The solvent of the extract solution is water.
[0147] For example, a DPPH free radical scavenging test was performed using an extract solution with a mass concentration of 1 mg / ml as an example, and the following sample tube (T), sample background (T0), DPPH tube (C) and solvent background (C0) were set:
[0148] Sample tube (T): 1 mL of extract solution (mass concentration is 1 mg / mL) + 2 mL of water + 1 ml of DPPH ethanol solution (DPPH concentration is 0.04 mg / mL);
[0149] Sample background tube (T0): 1 mL of extract solution (mass concentration is 1 mg / mL) + 2 mL of water + 1 ml of 95% ethanol solution;
[0150] DPPH tube (C): 3 mL of water + 1 mL of DPPH ethanol solution (the mass concentration of DPPH is 0.04 mg / mL);
[0151] Solvent background tube (C0): 3mL water + 1ml 95% ethanol solution.
[0152] The solutions in the above reaction tubes were transferred into cuvettes respectively, and the absorbance was measured at 517 nm. The DPPH free radical scavenging rates of extracts with different mass concentrations were calculated using the DPPH scavenging rate calculation formula. The specific results are as follows: Figure 6 shown.
[0153] ;
[0154] in, is the absorbance value of the sample tube; is the absorbance value of the sample background tube; is the absorbance value of the DPPH tube; is the absorbance value of the solvent background tube.
[0155] like Figure 6 As shown, Figure 6 Figure 3 is a schematic diagram of the DPPH free radical scavenging rate curve of extract B4 at different mass concentrations. When the mass concentration of extract B4 is 0.5 mg / mL, there is a significant difference in the scavenging of DPPH by the extract (p < 0.05), indicating that extract B4 has a good scavenging effect on DPPH, and with the increase of the mass concentration of extract B4, the DPPH scavenging rate gradually increases.
[0156] Test Example 10: Hydroxyl radical scavenging test of the extract
[0157] The extract B4 obtained under the optimal extraction process conditions of Example 4 was tested for scavenging hydroxyl radicals according to the following method.
[0158] Set up the sample tube (A 样品)、Loss pipe(A 损 )、Undamaged(A 未损 ), three parallel tubes are required for the sample tube (T) of each mass concentration of the extract, each of which is configured with extract solutions of different mass concentrations, and the solvent for diluting the extract solution is water.
[0159] Sample A (i.e., sample tube): 1 mL of o-phenanthroline ethanol solution (concentration: 5 mmol / L) + 2 mL of phosphate buffer (concentration: 0.2 mol / L) + 1 ml of extract solution + 1 mL of ferrous sulfate solution (5 mmol / L) + 1 mL of H2O2 solution (concentration: 0.1% v / v);
[0160] A loss (i.e. loss tube): 1 mL of o-phenanthroline ethanol solution (concentration of 5 mmol / L) + 2 mL of phosphate buffer (concentration of 0.2 mol / L) + 1 ml of ultrapure water + 1 mL of ferrous sulfate solution (5 mmol / L) + 1 mL of H2O2 solution (concentration of 0.1% v / v);
[0161] A: Undamaged (i.e., undamaged tube): 1 mL of 1-phenanthroline ethanol solution (concentration of 5 mmol / L) + 2 mL of phosphate buffer (concentration of 0.2 mol / L) + 1 mL of ferrous sulfate solution (5 mmol / L) + 2 mL of ultrapure water.
[0162] Place the sample tube (A 样品 )、Loss pipe(A 损 )、Undamaged(A 未损 ) were placed in a water bath at 37 °C for 1 h, and the absorbance of the solution was measured at a wavelength of 536 nm to obtain A 样品 , A 损 , A 未损 .
[0163] ;
[0164] Among them, A 样品 is the absorbance of the solution in the sample tube; A 损 A is the absorbance of the solution in the loss tube; 未损 is the absorbance of the solution in the intact tube.
[0165] like Figure 7 As shown, Figure 7 The figure is a schematic diagram of the hydroxyl radical scavenging curve of extract B4 at different mass concentrations. At 0.5 mg / mL, there was a significant difference in the scavenging of hydroxyl radicals by extract B4 (p < 0.05), indicating that extract B4 has a good scavenging effect on hydroxyl radicals, and with the increase of the mass concentration of extract B4, the hydroxyl radical scavenging rate gradually increases.
[0166] Test Example 11: Cytotoxicity test of the extract
[0167] Application of a Dendrobium officinale polysaccharide extract based on a lactic acid-based molecular machine: The Dendrobium officinale polysaccharide extract based on a lactic acid-based molecular machine (lactic acid betaine molecular machine) is used for cytotoxicity testing.
[0168] The extract B4 obtained under the optimal extraction process conditions of Example 4 was tested for toxicity to human skin fibroblasts.
[0169] Principle: The survival rate of cells is determined by metabolic activity. MTT (thiazolyl blue) is metabolically reduced in living cells to generate bluish-purple insoluble formazan. The number of living cells is related to the colorimetry measured by a photometer after the formazan is dissolved in alcohol.
[0170] step:
[0171] (1) Human keratinocytes and human skin fibroblasts were inoculated into 96-well plates with culture medium, 100 μL per well, and incubated for 24 h.
[0172] (2) After the cells adhered for 24 h, the culture medium was discarded and 100 μL of different mass concentrations of extract B4 solution (mass concentrations were 0.25 mg / mL, 0.5 mg / mL, 1 mg / mL, 2 mg / mL, 4 mg / mL, 8 mg / mL, and 16 mg / mL) was added to each well of the sample group. A blank group (no extract B4 solution was added, 100 μL of culture medium was added) and a negative group (no extract B4 solution was added, 100 μL of cell suspension and culture medium was added). Each mass concentration of the sample group, blank group, and negative group was set up with 3 wells, for a total of 54 wells.
[0173] (3) After the cells were incubated for 24 h, 10 μL of MTT (thiazolyl blue) solution was added to each well and the cells were cultured in an incubator for 4 h.
[0174] (4) Discard the culture medium and add 150 μL DMSO (dimethyl sulfoxide) to each well. After shaking for 10 min, measure the absorbance at 490 nm (OD490 nm) and compare it with the negative group that was not treated with the test substance extract B4 solution and calculate the results.
[0175] ;
[0176] in: is the average OD490 nm absorbance of the test substance extract B4 solution; —The average OD490 nm absorbance of the negative control group.
[0177] like Figure 8 As shown, Figure 8 This is a schematic diagram of the relative survival rate trend of human skin fibroblasts in the cytotoxicity test of the extract B4 solution of different mass concentrations in this application. When the relative cell survival rate is higher than 90%, it can be determined that the extract B4 solution has no biological toxicity at the corresponding concentration and has good biocompatibility. Based on human skin fibroblasts, within 2 mg / mL, the relative cell survival rate of the extract B4 solution is higher than 90%, which has good biocompatibility. Therefore, the test concentration of 2 mg / mL was selected for the subsequent anti-aging test based on human skin fibroblasts.
[0178] Test Example 11: Test on the effect of extract on the content of human type Ⅰ collagen
[0179] The extract B4 prepared in Example 4 was tested for the effect of human type I collagen content:
[0180] Principle: Based on human skin fibroblasts, the firming and anti-wrinkle effect of the sample to be tested is evaluated by detecting the changes in the synthesis content of human type I collagen; type I collagen is one of the main components of the extracellular matrix of the dermis. It is synthesized by dermal fibroblasts in the cell and secreted outside the cell. Under the action of terminal procollagen peptidase, the terminal peptides are separated and polymerized to form collagen fibers. Therefore, the firming and anti-wrinkle effect of the sample to be tested can be evaluated by the content of type I collagen secreted by fibroblasts after administration.
[0181] step:
[0182] (1) Human dermal fibroblasts were plated and cultured in 24-well plates.
[0183] (2) Solution preparation: Prepare working solutions of extract B4, positive control group (PC group) and negative control group (NC group) with different mass concentrations.
[0184] Negative control group: culture medium;
[0185] Positive control group: 100 mg / mL concentration of Vc (vitamin C);
[0186] Sample group 1: 0.5 mg / mL concentration of extract B4, the solvent is water;
[0187] Sample group 2: 1.0 mg / mL concentration of extract B4, the solvent is water;
[0188] Sample group 3: 2.0 mg / mL concentration of extract B4, the solvent is water;
[0189] (3) Drug addition: According to the above experimental plan, a negative control group, a positive control group, and 5 groups of extract B4 solutions with different mass concentrations were set up, with 3 replicates in each group and a total of 15 wells. When the fusion rate of human skin fibroblasts in the 24-well plate reached 40%-60%, drugs were added in groups. 250 μL of the corresponding working solution was added to each well, and the drugs were allowed to act for 72 h.
[0190] (4) The ELISA kit was used to measure the content of human type I collagen in the cell supernatant of each group.
[0191] like Fig. 9 As shown, Fig. 9 It is a schematic diagram of the effect of different mass concentrations of the extract B4 solution and the control group on the content of human type I collagen, that is, a relative content test diagram of human type I collagen in which different mass concentrations of the extract B4 solution and the control group of the present application are used to test the content of human type I collagen.
[0192] Test conclusion:
[0193] (1) Compared with the NC group, the level of human type Ⅰ collagen in the PC group was significantly increased (P < 0.05), indicating that the positive control of this experiment was effective.
[0194] (2) Compared with the NC group, the content of human type I collagen in the extract B4 solution at the test concentrations of 0.5 mg / mL, 1 mg / mL, and 2 mg / mL increased (P < 0.05). In addition, the content of human type I collagen increased with increasing concentrations. This means that the extract B4 solution has the ability to promote the synthesis of human type I collagen at concentrations of 0.5 mg / mL, 1 mg / mL, and 2 mg / mL, and has anti-wrinkle and firming effects in the above concentration ranges.
[0195] Test Example 12: Test on the release of MMP-1 from human skin fibroblasts in the extract
[0196] The extract B4 prepared in Example 4 was used to test the release of MMP-1 from human dermal fibroblasts.
[0197] Principle: The kit uses double antibody sandwich ELISA technology. Specific anti-human MMP-1 antibodies are pre-coated on high-affinity ELISA plates. Standards, samples to be tested, and biotinylated detection antibodies are added to the wells of the ELISA plate. After incubation, the MMP-1 present in the sample binds to the solid phase antibody and the detection antibody. After washing to remove unbound substances, horseradish peroxidase-labeled streptavidin (Streptavidin-HRP) is added. After washing, the color substrate TMB is added and the color is developed in the dark. The depth of the color reaction is proportional to the concentration of MMP-1 in the sample.
[0198] step:
[0199] (1) Human dermal fibroblasts were plated and cultured in 24-well plates for 18 h to 24 h.
[0200] (2) The cells were washed twice with PBS buffer, and the extract B4 with different mass concentrations, the maintenance culture medium for the positive control group (i.e., PC group), and the negative control group (i.e., NC group) were prepared.
[0201] Negative control group: culture medium;
[0202] Positive control group: 100 mg / mL concentration of Vc (vitamin C);
[0203] Sample group 1: 0.5 mg / mL concentration of extract B4, the solvent is water;
[0204] Sample group 2: 1.0 mg / mL concentration of extract B4, the solvent is water;
[0205] Sample group 3: 2.0 mg / mL concentration of extract B4, the solvent is water;
[0206] (3) Drug addition: According to the above experimental plan, a negative control group, a positive control group, and 5 groups of extract B4 solutions with different mass concentrations were set up, with 3 replicates in each group and a total of 15 wells. When the fusion rate of human skin fibroblasts in the 24-well plate reached 40%-60%, drugs were added in groups. 250 μL of the corresponding working solution was added to each well, and the drugs were allowed to act for 72 h.
[0207] (4) The ELISA kit was used to measure the MMP-1 content in the cell supernatant of each group.
[0208] like Fig.10 As shown, Fig.10 Schematic diagram of the MMP-1 relative content test of the MMP-1 release amount of human skin fibroblasts in the extract B4 solution with different mass concentrations and the control group.
[0209] Test conclusion:
[0210] (1) Compared with the NC group, the MMP-1 content in the PC group was significantly decreased (P<0.05), indicating that the positive control in this test was effective.
[0211] (2) Compared with NC, the MMP-1 content of the extract B4 solution at the test concentrations of 0.5 mg / mL, 1 mg / mL, and 2 mg / mL decreased significantly (P<0.05), and the MMP-1 content decreased more with the increase in concentration. This means that the extract B4 solution has the ability to inhibit the secretion of MMP-1 at the concentrations of 0.5 mg / mL, 1 mg / mL, and 2 mg / mL, and has anti-wrinkle and firming effects in the above concentration ranges.
[0212] Test Example 13: Test on the release of MMP-3 from human skin fibroblasts in the extract
[0213] The extract B4 prepared in Example 4 was used to test the release of MMP-3 from human dermal fibroblasts.
[0214] Principle: Irradiating cultured fibroblasts with UVA (long-wave ultraviolet) can lead to high expression of MMP-3 (matrix metalloproteinase) mRNA. The degradation of the extracellular matrix is closely related to MMP-3. When skin cells overexpress MMPs, the structure of the extracellular matrix of the dermis is severely damaged, especially the normal structure of collagen fibers and elastic fibers. The in vitro premature aging model of human skin fibroblasts induced by ultraviolet light is used to evaluate the anti-wrinkle effect of the test extract B4 by detecting the content of matrix metalloproteinase-3 (MMP-3) in the extracellular matrix.
[0215] step:
[0216] (1) Human dermal fibroblasts were plated and cultured in 24-well plates for 18 h to 24 h.
[0217] (2) Solution preparation: Prepare working solutions of extract B4, positive control group (PC group) and negative control group (NC group) with different mass concentrations.
[0218] Negative control group: culture medium;
[0219] Positive control group: 100 mg / mL concentration of Vc (vitamin C);
[0220] Sample group 1: 0.5 mg / mL concentration of extract B4, the solvent is water;
[0221] Sample group 2: 1.0 mg / mL concentration of extract B4, the solvent is water;
[0222] Sample group 3: 2.0 mg / mL concentration of extract B4, the solvent is water;
[0223] (3) Drug addition: According to the above experimental plan, a negative control group, a positive control group, and 5 groups of extract B4 solutions with different mass concentrations were set up, with 3 replicates in each group and a total of 15 wells. When the fusion rate of human skin fibroblasts in the 24-well plate reached 40%-60%, drugs were added in groups. 250 μL of the corresponding working solution was added to each well, and the drugs were allowed to act for 72 h.
[0224] (4) UVA stimulation: 4 h after drug administration, the groups that need stimulation are irradiated with UVA according to the above experimental scheme. After irradiation, the old culture medium is replaced with fresh culture medium in each well and the cells are placed in a cell culture incubator for another 20 h.
[0225] (5) The ELISA kit was used to measure the MMP-3 content in the cell supernatant of each group.
[0226] like Fig.11 As shown, Fig.11 This is a schematic diagram comparing the relative content of MMP-3 in the test of MMP-3 release from human skin fibroblasts using extract B4 solutions of different mass concentrations and the control group.
[0227] in conclusion:
[0228] (1) Compared with the NC group, the MMP-3 content in the PC group was significantly decreased, indicating that the positive control in this test was effective.
[0229] (2) Compared with the NC group, the MMP-3 content of the extract B4 solution at the test concentrations of 0.5 mg / mL, 1 mg / mL, and 2 mg / mL was significantly decreased (P<0.05), and the MMP-3 content decreased more with the increase in concentration. This means that the extract B4 solution has the ability to inhibit the secretion of MMP-3 at the concentrations of 0.5 mg / mL, 1 mg / mL, and 2 mg / mL, and has anti-wrinkle and firming effects in the above concentration ranges.
[0230] The present invention uses the prepared lactic acid-based molecular machine coupled with ultrasound-enhanced extraction technology to extract Dendrobium officinale polysaccharide compounds, and analyzes the formation driving force of the lactic acid-based molecular machine from a molecular level through infrared spectroscopy and quantum chemical calculation analysis; then, the optimal extraction conditions are obtained through single-factor experimental design: the concentration of the lactic acid betaine molecular machine is 40wt%, the extraction temperature is 60°C, and the extraction time is 1h.
[0231] The final polysaccharide extract (also called extract) of Dendrobium officinale has a polysaccharide yield of up to 197.6 mg / g, which is 2.35 times that of the water extraction method (84.2 mg / g). Lactic acid betaine molecular machines not only have higher extraction efficiency, but are also green solvents with anti-inflammatory, moisturizing, and anti-wrinkle effects. Their use can reduce waste, simplify process processing, and reduce costs. The Dendrobium officinale extract prepared above, whose main components are polysaccharides, lactic acid-based molecular machines, and water, can be used as a new type of cosmetic raw material to exert excellent antioxidant, anti-wrinkle, moisturizing and other effects.
[0232] The above description is only a preferred embodiment of the present application and is not intended to limit the present application. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present application should be included in the protection scope of the present application.
Claims
1. A lactic acid-based molecular machine, characterized in that including a first functional primitive and a second functional primitive; The first functional motif is bonded to the second functional motif via a hydrogen bond; The first functional unit is a lactic acid molecule, the second functional unit is at least one of a betaine molecule, a matrine molecule or a L-carnitine molecule, and the lactic acid-based molecular machine is used for extracting polysaccharides from Dendrobium officinale; Wherein, the Dendrobium officinale polysaccharide includes O-acetyl β-D-glucomannan, and the main chain of O-acetyl β-D-glucomannan is formed by D-mannose and D-glucose linked by β-1,4 glycosidic bonds; The lactic acid-based molecular machine is used to drive the lactic acid-based molecular machine to recognize and connect with the Dendrobium officinale polysaccharide through the affinity of the hydrogen bond, including driving the lactic acid-based molecular machine to recognize and connect with the β-1,4 glycosidic bond of the Dendrobium officinale polysaccharide through the affinity of the hydrogen bond; When the second functional unit is the betaine molecule, the molecular structure of the molecular machine is CH3CH(OH)COO-H-OOCCH2N(CH3)3; the hydrogen bond length is 1 Å~2 Å, wherein the hydrogen bond length is the bond length between the hydrogen (H) atom and the oxygen (O) atom in the betaine molecule.
2. The lactic acid-based molecular machine according to claim 1, wherein The molar ratio of the first functional unit to the second functional unit is 1:(0.25-4).
3. A method for preparing a lactic acid-based molecular machine as claimed in claim 1, characterized in that: The following steps are involved: Mixing at least one of the betaine, matrine or L-carnitine with lactic acid to obtain a mixed solution, and heating the mixed solution until the viscosity of the mixed solution is 200 mPa•s to 500 mPa•s to obtain a lactic acid-based molecular machine; Wherein, the temperature of the heating treatment is 30 ℃~60 ℃.
4. A method for preparing a polysaccharide extract of Dendrobium officinale, characterized in that: The following steps are involved: Step S100, mixing the Dendrobium officinale powder and the lactic acid-based molecular machine solution and then performing ultrasonic strengthening treatment to obtain a Dendrobium officinale extract; Step S200, centrifuging the Dendrobium officinale extract, filtering the supernatant after the centrifugation to obtain a Dendrobium officinale polysaccharide extract; Wherein, the solute in the lactic acid-based molecular machine solution is the lactic acid-based molecular machine according to claim 1 or 2, or, is the lactic acid-based molecular machine prepared by the preparation method according to claim 3.
5. The preparation method according to claim 4, characterized in that In the step S100, the mass volume ratio of the Dendrobium officinale powder to the lactic acid-based molecular machine solution is 1:5 g / mL to 70 g / mL; And / or, the particle size of the Dendrobium officinale powder is not greater than 0.3 mm.
6. The preparation method according to claim 4, characterized in that The concentration of the lactic acid-based molecular machine solution in step S100 is 5 wt% to 80 wt%.
7. The preparation method according to claim 5, characterized in that The parameters of the ultrasonic enhancement treatment in step S100 are: the ultrasonic enhancement treatment temperature is 30°C to 80°C, the ultrasonic enhancement treatment time is 0.5 h to 2 h, and the ultrasonic power is 100 W to 500 W.
8. The preparation method according to claim 5, characterized in that The parameters of the centrifugal treatment in step S200 are: a centrifugal treatment speed of 6000 r / min to 12000 r / min, a centrifugal treatment time of 5 min to 15 min, a centrifugal treatment filter membrane is an organic phase filter membrane, and the pore size of the organic phase filter membrane is not greater than 0.45 μm.
9. An antioxidant and anti-aging application of the Dendrobium officinale polysaccharide extract prepared by the preparation method according to any one of claims 4 to 8, characterized in that: The skin care product made from the Dendrobium officinale polysaccharide extract as a raw material is used for anti-oxidation and anti-aging repair of human skin.
10. The anti-oxidation and anti-aging application of the Dendrobium officinale polysaccharide extract according to claim 9, characterized in that: The Dendrobium officinale polysaccharide extract is also used for cytotoxicity test, human skin patch test or nine routine cosmetic tests.
